# Molbreeding Biotechnology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/molbreeding-biotechnology-co

- Industry: Agribusiness
- Headquarters: Shijiazhuang, China
- Website: www.molbreeding.com
- Total disclosed funding: $64M
- Latest round: Series B (Jul 30, 2024)
- Investors on record: 10

## About

Based in Shijiazhuang, China, and founded in 2017, Molbreeding Biotechnology Co., Ltd. is a molecular breeding technology developer that focuses on the agricultural molecular breeding filed. It has R&D centres in Beijing, Guangzhou, Hong Kong, the United States and the United Kingdom, and subsidiaries in Hainan, Nanjing, and the Netherlands. The company acquired certifications such as ISO9001, ISO14001, and ISO45001. In 2018, its first plant liquid phase chip product development is completed. In July 2024, the company raised CNY 250 million in series B funding led by new investor Jining State-own Capital.

The company mainly provides biological breeding services using animal and plant molecular detection and breeding technologies. The products can be categorized as equipment, software systems, liquid phase chips, and regent consumables. It has developed the iMBP Smart Breeding Factory, a smart laboratory platform for biological breeding. It also provides equipment such as gene amplification instruments and nucleic acid extraction platforms. The software systems include data analysis platforms, and information management systems. The liquid phase chips refer to breeding technology, and its R&D of new species includes crops, livestock, and aquaculture. The company also self-developed molecular breeding technology, such as targeted sequencing genotyping technology (Genotyping by Targeted Sequencing, GBTS) and GenoPlexs (multiplex PCR-based target sequencing).

The company generates revenue by providing biological breeding products and services such as equipment, software systems, liquid phase chips, and regent consumables. 

The company will use series B funding for biological breeding technology and platform research and development, and overseas business development.

## Funding rounds

- Series B, Jul 30, 2024, $34M — Suzhou International Development Venture Capital Holding, Dalton Venture, Lake Bleu Capital, Starlight Capital, Jining State-own Capital
- Series A, Feb 21, 2023, $14M — Boyu Capital, Alibaba Group, Yunzhi Capital, Starlight Capital, Shanghai Jihui Private Equity Fund Management
- Series A, Jun 14, 2022, $15M — Boyu Capital, Yunzhi Capital, Shanghai Jihui Private Equity Fund Management
- Series A, Sep 15, 2021 — CITIC Agriculture, Yunzhi Capital
- Angel, Apr 28, 2020 — CITIC Agriculture

## Investors

- CITIC Agriculture (https://capitalatlas.ai/funds/citic-agriculture) — Angel, Series A
- Yunzhi Capital — Series A
- Boyu Capital (https://capitalatlas.ai/funds/boyu-capital) — Series A
- Shanghai Jihui Private Equity Fund Management — Series A
- Alibaba Group — Series A
- Starlight Capital (https://capitalatlas.ai/funds/starlight-capital) — Series A, Series B
- Suzhou International Development Venture Capital Holding (https://capitalatlas.ai/funds/suzhou-international-development-venture-capital-holding) — Series B
- Dalton Venture (https://capitalatlas.ai/funds/dalton-venture) — Series B
- Lake Bleu Capital (https://capitalatlas.ai/funds/lake-bleu-capital) — Series B
- Jining State-own Capital — Series B
